• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国政府科技报告 >Expression and Significance of CYR61 Expression in Breast Cancer Tumor Specimens
【24h】

Expression and Significance of CYR61 Expression in Breast Cancer Tumor Specimens

机译：CYR61在乳腺癌肿瘤标本中的表达及意义

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Breast cancer often progresses from an estrogen (ER)-dependent, non- metastatic, antiestrogen-sensitive phenotype to an ER-independent, antiestrogen- resistant, highly invasive, and metastatic phenotype. To develop this aggressive phenotype, cells must circumvent normal tissue constraints and lose normal regulation of genes that control tissue homeostasis. Several prognostic markers in human breast cancers have been reported. Prediction of breast cancer recurrence can be assessed based on the size of the tumor, number of lymph nodes involved, estrogen receptor (ER) and progesterone receptor (PgR) status, and histological grade. It is known that adjuvant therapy improves long-term survival in breast cancer patients. In contrast to the invasive ER-negative breast carcinomas, the axillary nodenegative (ANN) breast cancer patients have a good prognosis; nevertheless, there is still an appreciable relapse rate. In general, adjuvant treatments benefit some patients with node-negative disease. However, large numbers of women (including those in whom no recurrence will occur) are treated in order to benefit those who will relapse. Thus, to reduce the toxicity and improve the efficacy of the drugs, we must identity appropriate adjuvant treatments for different groups of patients, and we should be able thereby to improve our predictions regarding which group of patents will benefit a treatment. We have identified Cyr6l, a member of a family of cysteine-rich secreted proteins. Cyr6l binds to the alphavP3 integrin and mediates cell attachment, adhesion, migration, extracellular matrix signaling, and angiogenesis. Cyr6l is expressed in all of the tumorigenic and metastatic breast cancer cell lines. We have shown that Cyr6l promotes antiestrogen resistance and that Cyr6l is expressed in 30% of human breast carcinomas, and that its expression correlates with HRG-expression and with the lack of ER expression.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号